AzTrials
AzTrials

Social NetworksPURPLENCT06798480

Prevalence of Problematic Use of Social Media

An observational study of Social Networks and Addiction, run by Hospices Civils de Lyon at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

In 2023, French individuals spend an average of two hours per day on social media platforms (SM), primarily Facebook, TikTok, X, YouTube, Instagram, and Snapchat. While social media offers undeniable benefits, it also raises concerns about its impact on mental health and well-being. Read more about this study

Who is it for?
Ages 13 years and olderHealthy volunteers can take part
Conditions the study is for
Social Networks, Addiction
What is being tested?
Self-administered survey
How many people
1,000 participants
Where
1 siteFrance
Study dates
1 Apr 2025to 1 Jul 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Panel population (probability sample):The first study population will consist of a panel of 3,900 participants provided by the Selvitys Institute. These participants are selected using probability sampling methods to ensure that they are representative of the general French population aged 13 years or older. The selection is based on key demographic characteristics such as age, gender, and geographic location, level of education, ensuring a diverse and balanced sample. Social media population (non-probability sample):The second study population will consist of individuals who voluntarily respond to the online self-administered questionnaire through recruitment campaigns on social media platforms. This non-probability sample is composed of individuals who actively use social media and are interested in participating. As participation is voluntary, the sample may not fully represent the broader French population but will provide insights into social media users' behavior and experiences

Who may be able to join

  • Aged 13 years or older.
  • Resident in France and French-speaking.
  • Does not object to participating in the study, and, for minors, whose parents also do not object to their participation.

Who cannot join

  • Unable to understand and complete the questionnaire (e.g., non-French-speaking).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

France1 site
  • Hospices Civils de Lyon

    Lyon, 69003

    Julia DE TERNAY, Dr, +33 04 72 11 78 52 ext. +33, Julia.daviau-de-ternay@chu-lyon.fr

    Julia DE TERNAY, Dr

Other trials in France

About this study

Official title: Prevalence of Problematic Use of Social Media in the General PopuLation

In 2023, French individuals spend an average of two hours per day on social media platforms (SM), primarily Facebook, TikTok, X, YouTube, Instagram, and Snapchat. While social media offers undeniable benefits, it also raises concerns about its impact on mental health and well-being. These impacts remain poorly understood, partly due to the diversity of social media uses and motivations, which do not have uniform effects on health. For instance, studies have shown that "active" use of social media (e.g., content creation) is associated with higher well-being, whereas "passive" use (e.g., content scrolling) is linked to lower well-being.

This challenge in understanding the variety of social media uses and their consequences has direct clinical implications. Clinicians working in pediatrics, child psychiatry, and addiction medicine are increasingly confronted with patients struggling to manage their social media use. However, they lack clear diagnostic criteria to differentiate between normal and problematic use, as well as specific tools tailored to address potential disorders.

Read more

Moreover, in France, there is no existing estimate of the proportion of the general population affected by problematic social media use.

This study aims to establish the prevalence of problematic use of social media in France. The investigators hypothesize that the prevalence will be close to 10%, which is the prevalence that has been found in other European countries in previous studies.

Being tested
Self-administered survey
Keywords
Problematic use, social media, addiction
Medical subject headings
Behavior, Addictive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-administered surveyOther

    An anonymous self-administered online questionnaire hosted on LimeSurvey, lasting approximately 20 minutes, will be completed by participants. A panel of participants representative of the general population will be provided by the Selvitys Institute. In parallel, the self-administered questionnaire will also be distributed via posts on social media platforms (Facebook, YouTube, Instagram, TikTok, Snapchat, and X) over a period of three months.

Study groups in NCT06798480
Study groupRoleWhat they receive
Social media usersAll French individuals aged 13 years or older who use social media
Receives: Other: Self-administered survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of problematic use of social media.

    Outcome measure: Problematic use will be identified if the participant endorses at least 6 out of 9 items on the French version of the Social Media Addiction Scale. The prevalence of problematic use will be calculated as the number of participants with problematic use divided by the total number of participants.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jan 2025
  2. Study start1 Apr 2025 (estimated)
  3. Primary completion1 Jul 2025 (estimated)
  4. Study completion1 Jul 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
1,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06798480
Sponsor's protocol ID
69HCL24_0042
Other IDs
2024-A02539-38
Acronym
PURPLE
Status last verified
Feb 2025
First submitted
20 Jan 2025
Last updated
5 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Social Networks and Addiction, run by Hospices Civils de Lyon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Julia DE TERNAY, Dr (+33 04 72 11 78 52 ext. +33, julia.daviau-de-ternay@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of problematic use of social media. (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in